Responsible Investment Team

BMO Global Asset Management’s heritage and commitment to ESG investing runs deep. We launched our first ESG fund in 1984 – and today offer a range of responsible strategies across asset types and geographies.

Our approach is an active one. We contribute to public policy development and engage with companies on ESG matters. And we express our views and perspectives through voting and thought leadership as well as working to ensure that ESG analysis is integrated across our broader investment processes.

Related capability

Responsible Investment

More articles by Responsible Investment Team

No posts matching your criteria

Preventing the antimicrobial resistance health crisis

Dame Sally Davies and James Anderson join the Sustainability Leaders podcast to discuss the history of antibiotic use on humans, livestock and plants that brought us to our current crisis today.

How can investors unlock sustainable opportunities?

How to embrace the opportunities that change creates

Achieving sustainability in the food production system

David Sneyd is joined by Jo Raven from the FAIRR Initiative to discuss the progress that is already underway to create a more sustainable food production system, including the rise of alternative, plant-based proteins in the food supply chain.

Why does antimicrobial resistance matter to food companies?

Antimicrobial resistance is accelerating at a rate that could threaten modern medicine. Why is it a material issue for food companies?

Why does antimicrobial resistance matter to pharmaceutical companies?

Antimicrobial resistance threatens our entire healthcare ecosystem. Why is it a particularly pressing issue for pharmaceutical companies?

The COVID-19 effect: Cybersecurity and data privacy

Discover how COVID-19 is impacting cybersecurity and data privacy

The ESG implications of COVID-19: Annual General Meetings (AGMs)

Discover how COVID-19 has pushed AGMs around the world into an online format.

The ESG implications of COVID-19: Executive Pay

Explore the executive pay implications of COVID-19 at top UK companies

BMO SDG Engagement Global Equity Strategy Impact Report 2020

In this report, we carry out a deep dive into our engagement activities, showing the alignment to the SDGs and their targets.

ESG Viewpoint – COVID-19 and the pharmaceutical industry

How is the pharmaceutical industry responding to COVID-19?

Investor engagement: lessons from the Global Financial Crisis

How did the global financial crisis shape investor engagement?

Investor engagement: routes to escalation

Discover investor engagement escalation strategies.

VIEW MORE